Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism
Table 4
Kinetic constants for trelagliptin determined from association progress curves.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Kinetic constants for trelagliptin determined from association progress curves.